Ipca Laboratories Ltd (BOM:524494)
₹ 1557.15 25.65 (1.67%) Market Cap: 395.06 Bil Enterprise Value: 400.99 Bil PE Ratio: 68.50 PB Ratio: 6.24 GF Score: 91/100

Full Year 2021 IPCA Laboratories Ltd Earnings Call Hosted by DAM Capital Advisors Ltd Transcript

May 31, 2021 / 05:30AM GMT
Release Date Price: ₹1035.55 (+2.31%)
Operator

Ladies and gentlemen, good day, and welcome to the Ipca Laboratories Q4 FY '21 Earnings Call, hosted by DAM Capital Advisors Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Nitin Agarwal from DAM Capital Advisors Limited. Thank you, and over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited, Research Division - Head of Research

Thanks, Monica. Good morning, everyone, and a very warm welcome to this Q4 FY '21 earnings call for Ipca Laboratories hosted by DAM Capital Advisors Private Limited.

On the call today representing the Ipca management team, Mr. A.K. Jain, our Joint Managing Director; and Mr. Harish Kamath, Company Secretary and Company Senior Corporate Counsel.

I will hand over the call to Mr. Jain to make some opening comments. And then we will open it for question and answers. Please go ahead, Mr. Jain.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, Joint MD & Executive Director

Thanks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot